FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Luka Milas

Research Profile

Living Beings

Chemicals & Drugs

Procedures

Physiology

Radiation Tolerance

Disorders

Anatomy

Tumor Cell Line

Co-author Network

Publications

TOP 3
Nancy R Hunter; Zhongxing Liao; Luka Milas; Howard D Thames; David Valdecanas; Kathy A Mason
Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib.
Li Wang; Carlo Toniatti; David Valdecanas; K. Kian Ang; Thomas Buchholz; Carolyn Buser-Doepner; Kathy A Mason; Anjili Mathur; Luka Milas
MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation.
Uma Raju; Oliver Riesterer; Zhi-Qiang Wang; Bonnie Glisson; Faye M Johnson; Luka Milas; David P Molkentine; Jessica M Molkentine; K. Kian Ang
Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Luka Milas (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nancy R Hunter; Zhongxing Liao; Luka Milas; Howard D Thames; David Valdecanas; Kathy A Mason
Mitigation and treatment of radiation-induced thoracic injury with a cyclooxygenase-2 inhibitor, celecoxib.
International journal of radiation oncology, biology, physics 2013;85(2):472-6.
2012: Li Wang; Carlo Toniatti; David Valdecanas; K. Kian Ang; Thomas Buchholz; Carolyn Buser-Doepner; Kathy A Mason; Anjili Mathur; Luka Milas
MK-4827, a PARP-1/-2 inhibitor, strongly enhances response of human lung and breast cancer xenografts to radiation.
Investigational new drugs 2012;30(6):2113-20.
2012: Uma Raju; Oliver Riesterer; Zhi-Qiang Wang; Bonnie Glisson; Faye M Johnson; Luka Milas; David P Molkentine; Jessica M Molkentine; K. Kian Ang
Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2012;105(2):241-9.
2012: Fumihiko Matsumoto; Luka Milas; K. Kian Ang; Kathryn A Mason; David N Valdecanas; Uma Raju
The impact of timing of EGFR and IGF-1R inhibition for sensitizing head and neck cancer to radiation.
Anticancer research 2012;32(8):3029-35.
2012: Daisuke Sano; David R Valdecanas; Ge Zhou; Jacob M Berlin; Daniela C Marcano; Luka Milas; Jeffrey N Myers; Tam T Pham; James M Tour
Noncovalent assembly of targeted carbon nanovectors enables synergistic drug and radiation cancer therapy in vivo.
ACS nano 2012;6(3):2497-505.
2011: Mylin A Torres; Uma Raju; David Molkentine; Oliver Riesterer; Luka Milas; K Kian Ang
AC480, formerly BMS-599626, a pan Her inhibitor, enhances radiosensitivity and radioresponse of head and neck squamous cell carcinoma cells in vitro and in vivo.
Investigational new drugs 2011;29(4):554-61.
2011: Li Wang; Peiying Yang; Zhen Zhang; Lorenzo Cohen; Zhiqiang Meng; Luka Milas; David Molkentine; Uma Raju; Zhongxing Liao
Huachansu, containing cardiac glycosides, enhances radiosensitivity of human lung cancer cells.
Anticancer research 2011;31(6):2141-8.
2011: Oliver Riesterer; Fumihiko Matsumoto; Li Wang; Jessica Pickett; David Molkentine; Uma Giri; Luka Milas; Uma Raju
A novel Chk inhibitor, XL-844, increases human cancer cell radiosensitivity through promotion of mitotic catastrophe.
Investigational new drugs 2011;29(3):514-22.
2011: Daisuke Sano; Fumihiko Matsumoto; David R Valdecanas; Mei Zhao; David P Molkentine; Yoko Takahashi; Ehab Y Hanna; Vassiliki A Papadimitrakopoulou; John V Heymach; Luka Milas; Jeffrey N Myers
Vandetanib restores head and neck squamous cell carcinoma cells' sensitivity to cisplatin and radiation in vivo and in vitro.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(7):1815-27.
2011: Oliver Riesterer; Qiuan Yang; Uma Raju; Mylin Torres; David Molkentine; Nalini Patel; David Valdecanas; Luka Milas; K Kian Ang
Combination of anti-IGF-1R antibody A12 and ionizing radiation in upper respiratory tract cancers.
International journal of radiation oncology, biology, physics 2011;79(4):1179-87.
2011: Ritsuko Komaki; Zhongxing Liao; Mary Frances McAleer; Luka Milas; Michael S O'Reilly; Xiong Wei; Pamela K Allen; George R Blumenschein; Joe Y Chang; James D Cox; Melenda Jeter; Merrill S Kies
Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer.
Frontiers in oncology 2011;1():52.
2010: Walter N Hittelman; Yong Liao; Li Wang; Luka Milas
Are cancer stem cells radioresistant?
Future oncology (London, England) 2010;6(10):1563-76.
2010: Ira Skvortsova; Sergej Skvortsov; Uma Raju; Taras Stasyk; Oliver Riesterer; Eva-Maria Schottdorf; Bela-Andre Popper; Bernhard Schiestl; Paul Eichberger; Paul Debbage; Andreas Neher; Guenther K Bonn; Lukas A Huber; Luka Milas; Peter Lukas
Epithelial-to-mesenchymal transition and c-myc expression are the determinants of cetuximab-induced enhancement of squamous cell carcinoma radioresponse.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2010;96(1):108-15.
2009: Heunglae Cho; Masashi Koto; Oliver Riesterer; David P Molkentine; Uma Giri; Luka Milas; Michael D Story; Chul Ha; Uma Raju
Imexon augments sensitivity of human lymphoma cells to ionizing radiation: in vitro experimental study.
Anticancer research 2009;29(11):4409-15.
2009: Oliver Riesterer; Kathryn A Mason; Uma Raju; Qiuan Yang; Li Wang; Walter N Hittelman; K Kian Ang; Luka Milas
Enhanced response to C225 of A431 tumor xenografts growing in irradiated tumor bed.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;92(3):383-7.
2009: Raymond E Meyn; Anapama Munshi; John V Haymach; Luka Milas; K Kian Ang
Receptor signaling as a regulatory mechanism of DNA repair.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2009;92(3):316-22.
2009: Wendy A Woodward; Robert G Bristow; Michael F Clarke; Robert P Coppes; Massimo Cristofanilli; Dan G Duda; John R Fike; Dolares Hambardzumyan; Richard P Hill; Craig T Jordan; Luka Milas; Frank Pajonk; Walter Curran; Adam Dicker; Yuhchyau Chen
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.
International journal of radiation oncology, biology, physics 2009;74(5):1580-91.
2009: Xianglin Yuan; Zhongxing Liao; Zhensheng Liu; Li-E Wang; Susan L Tucker; Li Mao; Xin Shelley Wang; Mary Martel; Ritsuko Komaki; James D Cox; Luka Milas; Qingyi Wei
Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(20):3370-8.
2009: Luka Milas; Walter N Hittelman
Cancer stem cells and tumor response to therapy: current problems and future prospects.
Seminars in radiation oncology 2009;19(2):96-105.
2009: Raymond E Meyn; Luka Milas; K Kian Ang
The role of apoptosis in radiation oncology.
International journal of radiation biology 2009;85(2):107-15.
2008: Oliver Riesterer; Luka Milas; K. Kian Ang
Combining molecular therapeutics with radiotherapy for head and neck cancer.
Journal of surgical oncology 2008;97(8):708-11.
2008: Kathryn A Mason; David Valdecanas; Nancy R Hunter; Luka Milas
INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin.
Investigational new drugs 2008;26(1):1-5.
2008: Klaus Dittmann; Claus Mayer; Petra A Ohneseit; Uma Raju; Nicolaus Andratschke; Luka Milas; H Peter Rodemann
Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
International journal of radiation oncology, biology, physics 2008;70(1):203-12.
2007: Keiko Shibuya; Ritsuko Komaki; Tomoaki Shintani; Satoshi Itasaka; Anderson Ryan; Juliane M Jürgensmeier; Luka Milas; Kian Ang; Roy S Herbst; Michael S O'Reilly
Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non-small-cell lung cancer.
International journal of radiation oncology, biology, physics 2007;69(5):1534-43.
2007: Juliette Thariat; Luka Milas; K. Kian Ang
Integrating radiotherapy with epidermal growth factor receptor antagonists and other molecular therapeutics for the treatment of head and neck cancer.
International journal of radiation oncology, biology, physics 2007;69(4):974-84.
2007: Nicole Wiedenmann; Masashi Koto; Uma Raju; Luka Milas; Kathryn A Mason
Modulation of tumor radiation response with G3139, a bcl-2 antisense oligonucleotide.
Investigational new drugs 2007;25(5):411-6.
2007: Oliver Riesterer; Luka Milas; K. Kian Ang
Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(26):4075-83.
2007: Guangying Zhu; Xianyi Cao; Joe Y Chang; Luka Milas; Sidney Wallace; Chun Li
Polymeric retinoid prodrug PG-4HPR enhances the radiation response of lung cancer.
Oncology reports 2007;18(3):645-51.
2007: Juliette Thariat; Gokcen Yildirim; Kathryn A Mason; Adam S Garden; Luka Milas; K. Kian Ang
Combination of radiotherapy with EGFR antagonists for head and neck carcinoma.
International journal of clinical oncology 2007;12(2):99-110.
2007: Nicole Wiedenmann; David Valdecanas; Nancy Hunter; Stephen Hyde; Thomas Buchholz; Luka Milas; Kathryn A Mason
130-nm albumin-bound paclitaxel enhances tumor radiocurability and therapeutic gain.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1868-74.
2007: Satoshi Itasaka; Ritsuko Komaki; Roy S Herbst; Keiko Shibuya; Tomoaki Shintani; Nancy Hunter; Amir Onn; Corazon D Bucana; Luka Milas; K. Kian Ang; Michael S O'Reilly
Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice.
International journal of radiation oncology, biology, physics 2007;67(3):870-8.
2007: Luka Milas; Fu-Min Fang; Kathryn A Mason; David Valdecanas; Nancy Hunter; Masashi Koto; K. Kian Ang
Importance of maintenance therapy in C225-induced enhancement of tumor control by fractionated radiation.
International journal of radiation oncology, biology, physics 2007;67(2):568-72.
2007: Zhongxing Liao; Kathryn A Mason; Luka Milas
Cyclo-oxygenase-2 and its inhibition in cancer: is there a role?
Drugs 2007;67(6):821-45.
2006: Eiko Nakata; Masakazu Fukushima; Yoshihiro Takai; Kenji Nemoto; Yoshihiro Ogawa; Takuma Nomiya; Yasuhiro Nakamura; Luka Milas; Shogo Yamada
S-1, an oral fluoropyrimidine, enhances radiation response of DLD-1/FU human colon cancer xenografts resistant to 5-FU.
Oncology reports 2006;16(3):465-71.
2006: Xifeng Wu; Jian Gu; Tsung-Teh Wu; Stephen G Swisher; Zhongxin Liao; Arlene M Correa; Jun Liu; Carol J Etzel; Christopher I Amos; Maosheng Huang; Silvia S Chiang; Luka Milas; Walter N Hittelman; Jaffer A Ajani
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(23):3789-98.
2006: Kathryn A Mason; Robert Neal; Nancy Hunter; Hisanori Ariga; K. Kian Ang; Luka Milas
CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):192-8.
2006: Uma Raju; Hisanori Ariga; Masashi Koto; Xueguan Lu; Jessica Pickett; David Valdecanas; Kathryn A Mason; Luka Milas
Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2006;80(2):185-91.
2006: Smith Apisarnthanarax; Mian M Alauddin; Firas Mourtada; Hisanori Ariga; Uma Raju; Osama Mawlawi; Dongmei Han; William G Bornmann; Jaffer A Ajani; Luka Milas; Juri G Gelovani; K.S. Chao
Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(15):4590-7.
2006: Thomas A DiPetrillo; Luka Milas; Devon Evans; Paul Akerman; Thomas Ng; Thomas Miner; Dennis Cruff; Bharti Chauhan; David A Iannitti; David Harrington; Howard Safran
Paclitaxel poliglumex (PPX-Xyotax) and concurrent radiation for esophageal and gastric cancer: a phase I study.
American journal of clinical oncology 2006;29(4):376-9.
2006: Michael R Horsman; Lothar Bohm; Geoffrey P Margison; Luka Milas; Jean-Francois Rosier; Geza Safrany; Edgar Selzer; Marcel Verheij; Jolyon H Hendry
Tumor radiosensitizers--current status of development of various approaches: report of an International Atomic Energy Agency meeting.
International journal of radiation oncology, biology, physics 2006;64(2):551-61.
2005: Luka Milas; Uma Raju; Zhongxing Liao; Jaffer A Ajani
Targeting molecular determinants of tumor chemo-radioresistance.
Seminars in oncology 2005;32(6 Suppl 9):S78-81.
2005: Uma Raju; Hisanori Ariga; Klaus Dittmann; Eiko Nakata; K. Kian Ang; Luka Milas
Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib.
International journal of radiation oncology, biology, physics 2005;63(2):520-8.
2005: Klaus Dittmann; Claus Mayer; Birgit Fehrenbacher; Martin Schaller; Uma Raju; Luka Milas; David J Chen; Rainer Kehlbach; H Peter Rodemann
Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase.
The Journal of biological chemistry 2005;280(35):31182-9.
2005: Zhongxing Liao; Ritsuko Komaki; Luka Milas; Chen Yuan; Merrill S Kies; Joe Y Chang; Melenda Jeter; Thomas Guerrero; George Blumenschien; Cheryl M Smith; Frank V Fossella; Barry Brown; James D Cox
A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3342-8.
2005: Ritsuko Komaki; Joe Y Chang; Xifeng Wu; Pamela K Allen; Luka Milas; Zhongxing Liao; Frank V Fossella; Elizabeth L Travis; Margaret R Spitz
Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapy.
Seminars in oncology 2005;32(2 Suppl 3):S92-8.
2005: Klaus Dittmann; Mahmoud Toulany; Johannes Classen; Vanessa Heinrich; Luka Milas; H Peter Rodemann
Selective radioprotection of normal tissues by Bowman-birk proteinase inhibitor (BBI) in mice.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2005;181(3):191-6.
2005: Kathryn A Mason; Hisanori Ariga; Robert Neal; David Valdecanas; Nancy Hunter; Arthur M Krieg; John K Whisnant; Luka Milas
Targeting toll-like receptor 9 with CpG oligodeoxynucleotides enhances tumor response to fractionated radiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(1):361-9.
2004: Luka Milas; Kathryn A Mason; Hisanori Ariga; Nancy Hunter; Robert Neal; David Valdecanas; Arthur M Krieg; John K Whisnant
CpG oligodeoxynucleotide enhances tumor response to radiation.
Cancer research 2004;64(15):5074-7.
2004: Zhongxing Liao; Luka Milas
COX-2 and its inhibition as a molecular target in the prevention and treatment of lung cancer.
Expert review of anticancer therapy 2004;4(4):543-60.
2004: Kathryn A Mason; Nancy Hunter; Uma Raju; Hisanori Ariga; Amir Husain; David Valdecanas; Robert Neal; K. Kian Ang; Luka Milas
Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
International journal of radiation oncology, biology, physics 2004;59(4):1181-9.
2004: Eiko Nakata; Nancy Hunter; Kathy Mason; Zhen Fan; K. Kian Ang; Luka Milas
C225 antiepidermal growth factor receptor antibody enhances the efficacy of docetaxel chemoradiotherapy.
International journal of radiation oncology, biology, physics 2004;59(4):1163-73.
2004: Nicolaus Andratschke; Klaus Dittmann; Kathryn A Mason; Zhen Fan; Zhongxing Liao; Ritsuko Komaki; K. Kian Ang; Luka Milas
Epidermal growth factor receptor as a target to improve treatment of lung cancer.
Clinical lung cancer 2004;5(6):340-52.
2004: David Raben; Cataldo Bianco; Luka Milas; K. Kian Ang
Targeted therapies and radiation for the treatment of head and neck cancer: are we making progress?
Seminars in radiation oncology 2004;14(2):139-52.
2004: Ritsuko Komaki; Jin Soo Lee; Luka Milas; Hoon K Lee; Frank V Fossella; Roy S Herbst; Pamela K Allen; Zhongxing Liao; Craig W Stevens; Charles Lu; Ralph G Zinner; Vassiliki A Papadimitrakopoulou; Merrill S Kies; George R Blumenschein; Katherine M W Pisters; Bonnie S Glisson; Jonathan M Kurie; Bunyamin Kaplan; Veronica P Garza; Deidre Mooring; Susan L Tucker; James D Cox
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
International journal of radiation oncology, biology, physics 2004;58(5):1369-77.
2004: William A Brock; Luka Milas; Sherry Bergh; Ruth Lo; Csaba Szabó; Kathryn A Mason
Radiosensitization of human and rodent cell lines by INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase.
Cancer letters 2004;205(2):155-60.
2004: Luka Milas; Zhen Fan; Nicolaus Andratschke; K. Kian Ang
Epidermal growth factor receptor and tumor response to radiation: in vivo preclinical studies.
International journal of radiation oncology, biology, physics 2004;58(3):966-71.
2004: K. Kian Ang; Nicolaus Andratschke; Luka Milas
Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy.
International journal of radiation oncology, biology, physics 2004;58(3):959-65.
2004: Sheikh M Ismail; Monica Puppi; Sheela Prithivirajsingh; Anupama Munshi; Uma Raju; Raymond E Meyn; Thomas Buchholz; Michael D Story; William A Brock; Luka Milas; Howard D Thames; Craig W Stevens
Predicting radiosensitivity using DNA end-binding complex analysis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1226-34.
2004: Ritsuko Komaki; Zhongxing Liao; Luka Milas
Improvement strategies for molecular targeting: Cyclooxygenase-2 inhibitors as radiosensitizers for non-small cell lung cancer.
Seminars in oncology 2004;31(1 Suppl 1):47-53.
2004: Eiko Nakata; Kathryn A Mason; Nancy Hunter; Amir Husain; Uma Raju; Zhongxing Liao; K. Kian Ang; Luka Milas
Potentiation of tumor response to radiation or chemoradiation by selective cyclooxygenase-2 enzyme inhibitors.
International journal of radiation oncology, biology, physics 2004;58(2):369-75.
2003: Ke Liang; Yang Lu; Weidong Jin; K. Kian Ang; Luka Milas; Zhen Fan
Sensitization of breast cancer cells to radiation by trastuzumab.
Molecular cancer therapeutics 2003;2(11):1113-20.
2003: Hak Choy; Luka Milas
Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance?
Journal of the National Cancer Institute 2003;95(19):1440-52.
2003: Ke Liang; K. Kian Ang; Luka Milas; Nancy Hunter; Zhen Fan
The epidermal growth factor receptor mediates radioresistance.
International journal of radiation oncology, biology, physics 2003;57(1):246-54.
2003: Zhongxing Liao; Luka Milas; Ritsuko Komaki; Craig Stevens; James D Cox
Combination of a COX-2 inhibitor with radiotherapy or radiochemotherapy in the treatment of thoracic cancer.
American journal of clinical oncology 2003;26(4):S85-91.
2003: Christopher H Crane; Kathy Mason; Nora Janjan; Luka Milas
Initial experience combining cyclooxygenase-2 inhibition with chemoradiation for locally advanced pancreatic cancer.
American journal of clinical oncology 2003;26(4):S81-4.
2003: Luka Milas
Cyclooxygenase-2 (COX-2) enzyme inhibitors and radiotherapy: preclinical basis.
American journal of clinical oncology 2003;26(4):S66-9.
2003: Thomas W Davis; Nancy Hunter; Ovidiu C Trifan; Luka Milas; Jaime L Masferrer
COX-2 inhibitors as radiosensitizing agents for cancer therapy.
American journal of clinical oncology 2003;26(4):S58-61.
2003: James D Cox; Naomi R Schechter; Andrew K Lee; Kenneth Forster; Craig W Stevens; K. Kian Ang; Ritsuko Komaki; Zhongxing Liao; Luka Milas
Uncertainties in physical and biological targeting with radiation therapy.
Rays 2003;28(3):211-5.
2003: Uma Raju; Eiko Nakata; Kathryn A Mason; K. Kian Ang; Luka Milas
Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
Cancer research 2003;63(12):3263-7.
2003: Zhongxing Liao; Ritsuko Komaki; Kathryn A Mason; Luka Milas
Role of cyclooxygenase-2 inhibitors in combination with radiation therapy in lung cancer.
Clinical lung cancer 2003;4(6):356-65.
2003: Luka Milas; Kathryn A Mason; Christopher H Crane; Zhongxing Liao; Jaime Masferrer
Improvement of radiotherapy or chemoradiotherapy by targeting COX-2 enzyme.
Oncology (Williston Park, N.Y.) 2003;17(5 Suppl 5):15-24.
2003: Ke Liang; Weidong Jin; Christiane Knuefermann; Mathias Schmidt; Gordon B Mills; K. Kian Ang; Luka Milas; Zhen Fan
Targeting the phosphatidylinositol 3-kinase/Akt pathway for enhancing breast cancer cells to radiotherapy.
Molecular cancer therapeutics 2003;2(4):353-60.
2003: Ivan Milas; Ritsuko Komaki; Tsutomu Hachiya; Robbin S Bubb; Jae Y Ro; Lauren Langford; Raymond Sawaya; Joe B Putnam; Pamela Allen; James D Cox; Timothy J McDonnell; William A Brock; Waun Ki Hong; Jack A Roth; Luka Milas
Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(3):1070-6.
2003: Luka Milas; Kathryn A Mason; Nancy Hunter; Chun Li; Sidney Wallace
Poly(L-glutamic acid)-paclitaxel conjugate is a potent enhancer of tumor radiocurability.
International journal of radiation oncology, biology, physics 2003;55(3):707-12.
2003: Luka Milas; Kathryn A Mason; Zhongxing Liao; K. Kian Ang
Chemoradiotherapy: emerging treatment improvement strategies.
Head & neck 2003;25(2):152-67.
2002: K. Kian Ang; Brian A Berkey; Xiaoyu Tu; Hua-Zhong Zhang; Ruth Katz; Elizabeth H Hammond; Karen K Fu; Luka Milas
Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.
Cancer research 2002;62(24):7350-6.
2002: David J Grdina; Yasushi Kataoka; Jeffrey S Murley; Kirsten Swedberg; John Y Lee; Nancy Hunter; Ralph R Weichselbaum; Luka Milas
Antimetastatic effectiveness of amifostine therapy following surgical removal of Sa-NH tumors in mice.
Seminars in oncology 2002;29(6 Suppl 19):22-8.
2002: Rafael Rosell; Frank Fossella; Luka Milas
Molecular markers and targeted therapy with novel agents: prospects in the treatment of non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2002;38 Suppl 4():43-9.
2002: Sachiko Nasu; Luka Milas; Shinichiro Kawabe; Uma Raju; Robert Newman
Enhancement of radiotherapy by oleandrin is a caspase-3 dependent process.
Cancer letters 2002;185(2):145-51.
2002: Uma Raju; Eiko Nakata; Peiying Yang; Robert A Newman; K. Kian Ang; Luka Milas
In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.
International journal of radiation oncology, biology, physics 2002;54(3):886-94.
2002: Robbin S Bubb; Ritsuko Komaki; Tsutomu Hachiya; Ivan Milas; Jae Y Ro; Lauren Langford; Raymond Sawaya; Joe B Putnam; Pamela Allen; James D Cox; Timothy J McDonnell; William A Brock; Waun Ki Hong; Jack A Roth; Luka Milas
Association of Ki-67, p53, and bcl-2 expression of the primary non-small-cell lung cancer lesion with brain metastatic lesion.
International journal of radiation oncology, biology, physics 2002;53(5):1216-24.
2002: Luka Milas
Docetaxel/radiation combinations: rationale and preclinical findings.
Clinical lung cancer 2002;3 Suppl 2():S29-36.
2002: Christopher H Crane; Nora Janjan; Kathy Mason; Luka Milas
Preoperative chemoradiation for locally advanced rectal cancer: emerging treatment strategies.
Oncology (Williston Park, N.Y.) 2002;16(5 Suppl 5):39-44.
2002: Vincent Grégoire; K. Kian Ang; Jean-François Rosier; Marc Beauduin; Adam S Garden; Marc Hamoir; Walter N Hittelman; Yves Humblet; Fadlo R Khuri; Luka Milas; Carine Mitine; Pierre Scalliet
A phase I study of fludarabine combined with radiotherapy in patients with intermediate to locally advanced head and neck squamous cell carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2002;63(2):187-93.
2002: Christopher H Crane; James L Abbruzzese; Douglas B Evans; Robert A Wolff; Matthew T. Ballo; Marc E Delclos; Luka Milas; Kathy Mason; Chusilp Charnsangavej; Peter W T Pisters; Jeffrey E Lee; Renato Lenzi; Jean-Nicolas Vauthey; A B S Wong; Thinh Phan; Q Nguyen; Nora Janjan
Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer?
International journal of radiation oncology, biology, physics 2002;52(5):1293-302.
2002: Luka Milas; Tetsuo Akimoto; Nancy Hunter; Kathryn A Mason; Lara Buchmiller; Michitaka Yamakawa; Hiroyuki Muramatsu; K. Kian Ang
Relationship between cyclin D1 expression and poor radioresponse of murine carcinomas.
International journal of radiation oncology, biology, physics 2002;52(2):514-21.
2002: David J Grdina; Yasushi Kataoka; Jeffrey S Murley; Nancy Hunter; Ralph R Weichselbaum; Luka Milas
Inhibition of spontaneous metastases formation by amifostine.
International journal of cancer. Journal international du cancer 2002;97(2):135-41.
2002: Ritsuko Komaki; Jin S Lee; Bunyamin Kaplan; P Allen; Jason F Kelly; Zhongxing Liao; Craig W Stevens; Frank V Fossella; Ralph G Zinner; Vassiliki A Papadimitrakopoulou; Fadlo R Khuri; Bonnie S Glisson; Katherine M W Pisters; Jonathan M Kurie; Roy Herbst; Luka Milas; Jae Y Ro; H D Thames; Waun Ki Hong; James D Cox
Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results.
Seminars in radiation oncology 2002;12(1 Suppl 1):46-9.
2001: Luka Milas
Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse.
Seminars in radiation oncology 2001;11(4):290-9.
2001: S Nasu; K. Kian Ang; Zhen Fan; Luka Milas
C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability.
International journal of radiation oncology, biology, physics 2001;51(2):474-7.
2001: Kathryn A Mason; Ritsuko Komaki; James D Cox; Luka Milas
Biology-based combined-modality radiotherapy: workshop report.
International journal of radiation oncology, biology, physics 2001;50(4):1079-89.
2001: Shi Ke; Luka Milas; Chusilp Charnsangavej; Sidney Wallace; Chun Li
Potentiation of radioresponse by polymer-drug conjugates.
Journal of controlled release : official journal of the Controlled Release Society 2001;74(1-3):237-42.
2001: Christopher H Crane; Robert A Wolff; James L Abbruzzese; Douglas B Evans; Luka Milas; Kathy Mason; Chusilp Charnsangavej; Peter W T Pisters; Jeffrey E Lee; Renato Lenzi; Sandeep Lahoti; Jean-Nicolas Vauthey; Nora Janjan
Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic index.
Seminars in oncology 2001;28(3 Suppl 10):25-33.
2001: Kathy Mason; A Staab; Nancy Hunter; W McBride; S Petersen; N Terry; Luka Milas
Enhancement of tumor radioresponse by docetaxel: Involvement of immune system.
International journal of oncology 2001;18(3):599-606.
2001: Christopher H Crane; Nora Janjan; Douglas B Evans; Robert A Wolff; Matthew T. Ballo; Luka Milas; Kathy Mason; Chusilp Charnsangavej; Peter W T Pisters; Jeffrey E Lee; Renato Lenzi; Jean-Nicolas Vauthey; Adrian Wong; Thinh Phan; Q Nguyen; James L Abbruzzese
Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer.
International journal of pancreatology : official journal of the International Association of Pancreatology 2001;29(1):9-18.
2001: T P Phan; Christopher H Crane; Nora Janjan; E Vrdoljak; Luka Milas; Kathryn A Mason
WR-2721 reduces intestinal toxicity from concurrent gemcitabine and radiation treatment.
International journal of pancreatology : official journal of the International Association of Pancreatology 2001;29(1):19-23.
2000: Chun Li; Shi Ke; Qing-Ping Wu; W Tansey; Nancy Hunter; Lara Buchmiller; Luka Milas; Chusilp Charnsangavej; Sidney Wallace
Potentiation of ovarian OCa-1 tumor radioresponse by poly (L-glutamic acid)-paclitaxel conjugate.
International journal of radiation oncology, biology, physics 2000;48(4):1119-26.
2000: Carsten Nieder; Luka Milas; K. Kian Ang
Tissue tolerance to reirradiation.
Seminars in radiation oncology 2000;10(3):200-9.
2000: Chun Li; Shi Ke; Qing-Ping Wu; W Tansey; Nancy Hunter; Lara Buchmiller; Luka Milas; Chusilp Charnsangavej; Sidney Wallace
Tumor irradiation enhances the tumor-specific distribution of poly(L-glutamic acid)-conjugated paclitaxel and its antitumor efficacy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(7):2829-34.
2000: C Petersen; S Petersen; Luka Milas; Frederick F Lang; Philip J Tofilon
Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2513-20.
2000: Kazushi Kishi; S Petersen; C Petersen; Nancy Hunter; Kathy Mason; J L Masferrer; Philip J Tofilon; Luka Milas
Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
Cancer research 2000;60(5):1326-31.
2000: N Oriuchi; T Jibu; Luka Milas; J Choe; L Kuang; E Edmund Kim; Nancy Hunter; S Wallace; Donald A Podoloff
Assessment of resistance to paclitaxel of murine tumors by (99m)Tc-MIBI/(201)Tl dual-radionuclide imaging.
Nuclear medicine and biology 2000;27(2):127-33.
2000: Luka Milas; Kathy Mason; Nancy Hunter; S Petersen; M Yamakawa; K. Kian Ang; John Mendelsohn; Zhen Fan
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(2):701-8.
1999: Kathryn A Mason; Kazushi Kishi; Nancy Hunter; Lara Buchmiller; Tetsuo Akimoto; Ritsuko Komaki; Luka Milas
Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4191-8.
1999: Tetsuo Akimoto; Nancy Hunter; Lara Buchmiller; Kathy Mason; K. Kian Ang; Luka Milas
Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(10):2884-90.
1999: Luka Milas; Kazushi Kishi; Nancy Hunter; Kathy Mason; J L Masferrer; Philip J Tofilon
Enhancement of tumor response to gamma-radiation by an inhibitor of cyclooxygenase-2 enzyme.
Journal of the National Cancer Institute 1999;91(17):1501-4.
1999: V Gregoire; Walter N Hittelman; Jean-François Rosier; Luka Milas
Chemo-radiotherapy: radiosensitizing nucleoside analogues (review).
Oncology reports 1999;6(5):949-57.
1999: Kathryn A Mason; Luka Milas; Nancy Hunter; Mohamed A Elshaikh; Lara Buchmiller; Kazushi Kishi; K Hittelman; K. Kian Ang
Maximizing therapeutic gain with gemcitabine and fractionated radiation.
International journal of radiation oncology, biology, physics 1999;44(5):1125-35.
1999: Linh N Nguyen; Ritsuko Komaki; Pamela Allen; RA Schea; Luka Milas
Effectiveness of accelerated radiotherapy for patients with inoperable non-small cell lung cancer (NSCLC) and borderline prognostic factors without distant metastasis: a retrospective review.
International journal of radiation oncology, biology, physics 1999;44(5):1053-6.
1999: T Inoue; Chun Li; David J Yang; T Higuchi; N Oriuchi; Dihua Yu; Luka Milas; Nancy Hunter; Sidney Wallace; E Edmund Kim; D A Podoloff
Evaluation of In-111 DTPA-paclitaxel scintigraphy to predict response on murine tumors to paclitaxel.
Annals of nuclear medicine 1999;13(3):169-74.
1999: Tetsuo Akimoto; J Seong; Nancy Hunter; Lara Buchmiller; Kathy Mason; Luka Milas
Association of increased radiocurability of murine carcinomas with low constitutive expression of p21(WAF1/CIP1) protein.
International journal of radiation oncology, biology, physics 1999;44(2):413-9.
1999: David J Grdina; Nancy Hunter; Yasushi Kataoka; Jeffrey S Murley; Luka Milas
Chemopreventive doses of amifostine confer no cytoprotection to tumor nodules growing in the lungs of mice treated with cyclophosphamide.
Seminars in oncology 1999;26(2 Suppl 7):22-7.
1999: MD Logsdon; Raymond E Meyn; PC Besa; WC Pugh; L Clifton Stephens; LJ Peters; Luka Milas; James D Cox; Fernando Cabanillas; Shawn Brisbay; M Andersen; Timothy J McDonnell
Apoptosis and the Bcl-2 gene family -- patterns of expression and prognostic value in stage I and II follicular center lymphoma.
International journal of radiation oncology, biology, physics 1999;44(1):19-29.
1999: Chun Li; Janet E Price; Luka Milas; Nancy Hunter; Shi Ke; Dong-Fang Yu; Chusilp Charnsangavej; Sidney Wallace
Antitumor activity of poly(L-glutamic acid)-paclitaxel on syngeneic and xenografted tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(4):891-7.
1999: Luka Milas; MM Milas; Kathryn A Mason
Combination of taxanes with radiation: preclinical studies.
Seminars in radiation oncology 1999;9(2 Suppl 1):12-26.
1999: T Akimoto; Shinichiro Kawabe; A Grothey; Luka Milas
Low E-cadherin and beta-catenin expression correlates with increased spontaneous and artificial lung metastases of murine carcinomas.
Clinical & experimental metastasis 1999;17(2):171-6.
1999: Luka Milas; T Fujii; Nancy Hunter; Mohamed A Elshaikh; Kathy Mason; William Plunkett; K. Kian Ang; Walter N Hittelman
Enhancement of tumor radioresponse in vivo by gemcitabine.
Cancer research 1999;59(1):107-14.
1998: Chun Li; Dong-Fang Yu; Robert A Newman; F Cabral; L Clifton Stephens; Nancy Hunter; Luka Milas; Sidney Wallace
Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate.
Cancer research 1998;58(11):2404-9.
1998: Ritsuko Komaki; Luka Milas; Jae Y Ro; T Fujii; P Perkins; Pamela Allen; Charles R Sikes; C F Mountain; Nelson G Ordonez
Prognostic biomarker study in pathologically staged N1 non-small cell lung cancer.
International journal of radiation oncology, biology, physics 1998;40(4):787-96.
1997: Kathryn A Mason; Nancy Hunter; MM Milas; James L Abbruzzese; Luka Milas
Docetaxel enhances tumor radioresponse in vivo.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2431-8.
1997: CG Milross; Kathryn A Mason; Nancy Hunter; N H Terry; N Patel; S Harada; T Jibu; J Seong; Luka Milas
Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo.
European journal of cancer (Oxford, England : 1990) 1997;33(8):1299-308.
1997: Chun Li; Dong-Fang Yu; T Inoue; David J Yang; W Tansey; CW Liu; Luka Milas; Nancy Hunter; E Edmund Kim; Sidney Wallace
Synthesis, biodistribution and imaging properties of indium-111-DTPA-paclitaxel in mice bearing mammary tumors.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(7):1042-7.
1997: Y Saito; CG Milross; W N Hittelman; D Li; T Jibu; L J Peters; Luka Milas
Effect of radiation and paclitaxel on p53 expression in murine tumors sensitive or resistant to apoptosis induction.
International journal of radiation oncology, biology, physics 1997;38(3):623-31.
1997: Raymond E Meyn; Luka Milas; L Clifton Stephens
Apoptosis in tumor biology and therapy.
Advances in experimental medicine and biology 1997;400B():657-67.
1997: Luka Milas; V Gregoire; Nancy Hunter; B Kurdoglu; Kathy Mason; Raymond E Meyn
Radiation-induced apoptosis in tumors: effect of radiation modulating agents.
Advances in experimental medicine and biology 1997;400B():559-64.
1997: J Seong; CG Milross; Nancy Hunter; H C Shin; Luka Milas
Potentiation of antitumor efficacy of paclitaxel by recombinant tumor necrosis factor-alpha.
Anti-cancer drugs 1997;8(1):80-7.
1997: CG Milross; Susan L Tucker; Kathryn A Mason; Nancy Hunter; L J Peters; Luka Milas
The effect of tumor size on necrosis and polarographically measured pO2.
Acta oncologica (Stockholm, Sweden) 1997;36(2):183-9.
1996: T Inoue; David J Yang; Sidney Wallace; A Cherif; W Tansey; E Edmund Kim; Nancy Hunter; CG Milross; Luka Milas; Donald A Podoloff
Evaluation of [131I]iodoerythronitroimidazole as a predictor for the radiosensitizing effect.
Anti-cancer drugs 1996;7(8):858-65.
1996: V Grégoire; Nancy Hunter; W A Brock; Walter N Hittelman; William Plunkett; Luka Milas
Improvement in the therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus fludarabine.
Radiation research 1996;146(5):548-53.
1996: Ritsuko Komaki; T Fujii; P Perkins; Jae Y Ro; Pamela K Allen; Kathryn A Mason; C F Mountain; Luka Milas
Apoptosis and mitosis as prognostic factors in pathologically staged N1 nonsmall cell lung cancer.
International journal of radiation oncology, biology, physics 1996;36(3):601-5.
1996: CG Milross; Kathryn A Mason; Nancy Hunter; W K Chung; LJ Peters; Luka Milas
Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel.
Journal of the National Cancer Institute 1996;88(18):1308-14.
1996: Chun Li; D Yu; T Inoue; David J Yang; Luka Milas; Nancy Hunter; E Edmund Kim; Sidney Wallace
Synthesis and evaluation of water-soluble polyethylene glycol-paclitaxel conjugate as a paclitaxel prodrug.
Anti-cancer drugs 1996;7(6):642-8.
1996: Luka Milas; Y Saito; Nancy Hunter; CG Milross; Kathryn A Mason
Therapeutic potential of paclitaxel-radiation treatment of a murine ovarian carcinoma.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1996;40(2):163-70.
1996: Howard D Thames; Arnout C Ruifrok; Luka Milas; Nancy Hunter; Kathryn A Mason; Nicholas H A Terry; R A White
Accelerated repopulation during fractionated irradiation of a murine ovarian carcinoma: downregulation of apoptosis as a possible mechanism.
International journal of radiation oncology, biology, physics 1996;35(5):951-62.
1996: Luka Milas; CG Milross; Kathryn A Mason
Cytotoxic treatments and tumor oxygenation.
The cancer journal from Scientific American 1996;2(1):59-60; author reply 60-1.
1995: CG Milross; LJ Peters; Nancy Hunter; Kathryn A Mason; Luka Milas
Sequence-dependent antitumor activity of paclitaxel (taxol) and cisplatin in vivo.
International journal of cancer. Journal international du cancer 1995;62(5):599-604.
1995: Luka Milas; W R Hanson
Eicosanoids and radiation.
European journal of cancer (Oxford, England : 1990) 1995;31A(10):1580-5.
1995: Luka Milas; Nancy Hunter; Kathryn A Mason; CG Milross; Y Saito; LJ Peters
Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel.
Cancer research 1995;55(16):3564-8.
1995: J A Wheeler; L Clifton Stephens; Carmen Tornos; Patricia J Eifel; K. Kian Ang; Luka Milas; Pamela K Allen; Raymond E Meyn
ASTRO Research Fellowship: apoptosis as a predictor of tumor response to radiation in stage IB cervical carcinoma. American Society for Therapeutic Radiology and Oncology.
International journal of radiation oncology, biology, physics 1995;32(5):1487-93.
1995: Kathryn A Mason; Luka Milas; LJ Peters
Effect of paclitaxel (taxol) alone and in combination with radiation on the gastrointestinal mucosa.
International journal of radiation oncology, biology, physics 1995;32(5):1381-9.
1995: Raymond E Meyn; L Clifton Stephens; Nancy Hunter; Luka Milas
Apoptosis in murine tumors treated with chemotherapy agents.
Anti-cancer drugs 1995;6(3):443-50.
1995: Raymond E Meyn; L Clifton Stephens; Nancy Hunter; Luka Milas
Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas.
International journal of cancer. Journal international du cancer 1995;60(5):725-9.
1995: Luka Milas; Nancy Hunter; B Kurdoglu; Kathryn A Mason; Raymond E Meyn; L Clifton Stephens; LJ Peters
Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol.
Cancer chemotherapy and pharmacology 1995;35(4):297-303.
1995: Luka Milas; Nancy Hunter; Kathryn A Mason; CG Milross; LJ Peters
Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse.
Acta oncologica (Stockholm, Sweden) 1995;34(3):409-12.
1994: V Grégoire; NT Van; L Clifton Stephens; W A Brock; Luka Milas; William Plunkett; Walter N Hittelman
The role of fludarabine-induced apoptosis and cell cycle synchronization in enhanced murine tumor radiation response in vivo.
Cancer research 1994;54(23):6201-9.
1994: Raymond E Meyn; L Clifton Stephens; Nancy Hunter; K. Kian Ang; Luka Milas
Reemergence of apoptotic cells between fractionated doses in irradiated murine tumors.
International journal of radiation oncology, biology, physics 1994;30(3):619-24.
1994: N Mirkovic; Raymond E Meyn; N R Hunter; Luka Milas
Radiation-induced apoptosis in a murine lymphoma in vivo.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;33(1):11-6.
1994: V Grégoire; Nancy Hunter; W A Brock; Luka Milas; William Plunkett; Walter N Hittelman
Fludarabine improves the therapeutic ratio of radiotherapy in mouse tumors after single-dose irradiation.
International journal of radiation oncology, biology, physics 1994;30(2):363-71.
1994: Luka Milas; Nancy Hunter; Kathryn A Mason; B Kurdoglu; LJ Peters
Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel.
Cancer research 1994;54(13):3506-10.
1994: Luka Milas; T Nakayama; Nancy Hunter; S Jones; T M Lin; S Yamada; Howard D Thames; L Peters
Dynamics of tumor cell clonogen repopulation in a murine sarcoma treated with cyclophosphamide.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 1994;30(3):247-53.
1994: H Ito; Ritsuko Komaki; Luka Milas
Protection by WR-2721 against radiation plus cis-diamminedichloroplatinum II caused injury to colonic epithelium in mice.
International journal of radiation oncology, biology, physics 1994;28(4):899-903.
1994: Alan Pollack; Nicholas H A Terry; R A White; S Cao; Marvin L Meistrich; Luka Milas
Proliferation kinetics of recruited cells in a mouse mammary carcinoma.
Cancer research 1994;54(3):811-7.
1994: V Grégoire; Nancy Hunter; Luka Milas; W A Brock; William Plunkett; Walter N Hittelman
Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
Cancer research 1994;54(2):468-74.
1994: Raymond E Meyn; L Clifton Stephens; Nancy Hunter; Luka Milas
Induction of apoptosis in murine tumors by cyclophosphamide.
Cancer chemotherapy and pharmacology 1994;33(5):410-4.
1993: Raymond E Meyn; L Clifton Stephens; David Voehringer; Michael D Story; N Mirkovic; Luka Milas
Biochemical modulation of radiation-induced apoptosis in murine lymphoma cells.
Radiation research 1993;136(3):327-34.
1993: Kathryn A Mason; S Murphy; Luka Milas
Stimulation of hematopoietic cell recovery by tetrachlorodecaoxide in sublethally irradiated mice.
Radiation research 1993;136(2):229-35.
1993: Raymond E Meyn; L Clifton Stephens; K. Kian Ang; Nancy Hunter; W A Brock; Luka Milas; LJ Peters
Heterogeneity in the development of apoptosis in irradiated murine tumours of different histologies.
International journal of radiation biology 1993;64(5):583-91.
1993: PC Besa; Nancy Hunter; Luka Milas
Improvement in radiotherapy for a murine sarcoma by indomethacin plus WR-2721.
Radiation research 1993;135(1):93-7.
1993: L Clifton Stephens; Nancy Hunter; K. Kian Ang; Luka Milas; Raymond E Meyn
Development of apoptosis in irradiated murine tumors as a function of time and dose.
Radiation research 1993;135(1):75-80.
1992: Nancy Hunter; T Nakayama; H Ito; S Woo; Luka Milas
Combination of interleukin-2 and irradiation in therapy of murine tumors.
Clinical & experimental metastasis 1992;10(6):431-6.
1992: Luka Milas; I Nishiguchi; Nancy Hunter; D Murray; R Fleck; H Ito; Elizabeth L Travis
Radiation protection against early and late effects of ionizing irradiation by the prostaglandin inhibitor indomethacin.
Advances in space research : the official journal of the Committee on Space Research (COSPAR) 1992;12(2-3):265-71.
1992: B W Brown; J R Thompson; Luka Milas
Effects of size and growth time of a murine sarcoma on its metastatic spread.
Clinical & experimental metastasis 1992;10(1):77-86.
1992: Nancy Hunter; R Guttenberger; Luka Milas
Modification of radiation-induced carcinogenesis in mice by misonidazole and WR-2721.
International journal of radiation oncology, biology, physics 1992;22(4):795-8.
1991: Luka Milas; S Yamada; Nancy Hunter; R Guttenberger; Howard D Thames
Changes in TCD50 as a measure of clonogen doubling time in irradiated and unirradiated tumors.
International journal of radiation oncology, biology, physics 1991;21(5):1195-202.
1991: Garth L Nicolson; S E Custead; K M Dulski; Luka Milas
Effects of gamma irradiation on cultured rat and mouse microvessel endothelial cells: metastatic tumor cell adhesion, subendothelial matrix degradation, and secretion of tumor cell growth factors.
Clinical & experimental metastasis 1991;9(5):457-68.
1991: L Clifton Stephens; K. Kian Ang; Timothy Schultheiss; Luka Milas; Raymond E Meyn
Apoptosis in irradiated murine tumors.
Radiation research 1991;127(3):308-16.
1991: Luka Milas; H Ito; T Nakayama; Nancy Hunter
Improvement in therapeutic ratio of radiotherapy for a murine sarcoma by indomethacin plus misonidazole.
Cancer research 1991;51(14):3639-42.
1991: Luka Milas; Nancy Hunter; Y Furuta; I Nishiguchi; S Runkel
Antitumour effects of indomethacin alone and in combination with radiotherapy: role of inhibition of tumour angiogenesis.
International journal of radiation biology 1991;60(1-2):65-70.
1991: S Runkel; Nancy Hunter; Luka Milas
An intradermal assay for quantification and kinetics studies of tumor angiogenesis in mice.
Radiation research 1991;126(2):237-43.
1990: Luka Milas
Tumor bed effect in murine tumors: relationship to tumor take and tumor macrophage content.
Radiation research 1990;123(2):232-6.
1990: Luka Milas; Y Furuta; Nancy Hunter; I Nishiguchi; S Runkel
Dependence of indomethacin-induced potentiation of murine tumor radioresponse on tumor host immunocompetence.
Cancer research 1990;50(15):4473-7.
1990: J P Volpe; Luka Milas
Influence of tumor transplantation methods on tumor growth rate and metastatic potential of solitary tumors derived from metastases.
Clinical & experimental metastasis 1990;8(4):381-9.
1990: D Murray; A Prager; S C Vanankeren; E M Altschuler; M S Kerr; Nicholas H A Terry; Luka Milas
Comparative effect of the thiols dithiothreitol, cysteamine and WR-151326 on survival and on the induction of DNA damage in cultured Chinese hamster ovary cells exposed to gamma-radiation.
International journal of radiation biology 1990;58(1):71-91.
1990: I Nishiguchi; Y Furuta; Nancy Hunter; D Murray; Luka Milas
Radioprotection of hematopoietic tissues in mice by indomethacin.
Radiation research 1990;122(2):188-92.
1990: I Nishiguchi; V Willingham; Luka Milas
Tumor necrosis factor as an adjunct to fractionated radiotherapy in the treatment of murine tumors.
International journal of radiation oncology, biology, physics 1990;18(3):555-8.
1990: J P Volpe; I Basic; Luka Milas
Metastatic abilities of murine sarcomas and carcinomas. II. Relationship to cell volume and DNA index.
Clinical & experimental metastasis 1990;8(2):193-201.
1989: D Murray; E M Altschuler; Nancy Hunter; Luka Milas
Protection by WR-3689 against gamma-ray-induced intestinal damage: comparative effect on clonogenic cell survival, mouse survival, and DNA damage.
Radiation research 1989;120(2):339-51.
1989: D Murray; A Prager; Luka Milas
Radioprotection of cultured mammalian cells by the aminothiols WR-1065 and WR-255591: correlation between protection against DNA double-strand breaks and cell killing after gamma radiation.
Radiation research 1989;120(1):154-63.
1989: Luka Milas; G Sersa; V Willingham; Nancy Hunter; S Woo
Adoptive immunotherapy as an adjunctive treatment to thoracic irradiation for pulmonary tumor deposits in mice.
Cancer research 1989;49(18):4979-82.
1989: S C vanAnkeren; Luka Milas; D Murray
Protection of cultured Chinese hamster ovary cells by the aminothiol WR-255591 from the lethal and DNA-damaging effects of fast neutrons.
International journal of radiation oncology, biology, physics 1989;16(5):1205-8.
1989: M Iwakawa; Philip J Tofilon; C Arundel; Luka Milas
Combination of N-methylformamide with cis-diamminedichloroplatinum (II) in murine mammary carcinoma: importance of timing.
Cancer research 1989;49(7):1640-3.
1988: K. Kian Ang; Howard D Thames; S D Jones; G L Jiang; Luka Milas; LJ Peters
Proliferation kinetics of a murine fibrosarcoma during fractionated irradiation.
Radiation research 1988;116(2):327-36.
1988: D Murray; E M Altschuler; M S Kerr; S C Vanankeren; Raymond E Meyn; Luka Milas
Radioprotection of cultured Chinese hamster ovary cells by WR-255591.
International journal of radiation biology 1988;54(2):269-83.
1988: G Sersa; V Willingham; Luka Milas
Anti-tumor effects of tumor necrosis factor alone or combined with radiotherapy.
International journal of cancer. Journal international du cancer 1988;42(1):129-34.
1988: J P Volpe; Luka Milas
Metastatic instability of murine tumor metastases: dependence on tumor type.
Clinical & experimental metastasis 1988;6(4):333-46.
1988: Y Furuta; Nancy Hunter; T Barkley; E Hall; Luka Milas
Increase in radioresponse of murine tumors by treatment with indomethacin.
Cancer research 1988;48(11):3008-13.
1988: Y Furuta; E R Hall; S Sanduja; T Barkley; Luka Milas
Prostaglandin production by murine tumors as a predictor for therapeutic response to indomethacin.
Cancer research 1988;48(11):3002-7.
1988: Nicholas H A Terry; K. Kian Ang; Nancy Hunter; Luka Milas
Tissue repair and repopulation in the tumor bed effect.
Radiation research 1988;114(3):621-6.
1988: D Murray; Luka Milas; Raymond E Meyn
Radioprotection of mouse jejunum by WR-2721 and WR-1065: effects on DNA strand-break induction and rejoining.
Radiation research 1988;114(2):268-80.
1988: Luka Milas; H Hirata; Nancy Hunter; LJ Peters
Effect of radiation-induced injury of tumor bed stroma on metastatic spread of murine sarcomas and carcinomas.
Cancer research 1988;48(8):2116-20.
1988: M Iwakawa; Luka Milas
The effect of N-methylformamide on radiocurability of murine tumors.
Radiation research 1988;113(1):199-203.
1988: D Murray; S C VanAnkeren; Luka Milas; Raymond E Meyn
Radioprotective action of WR-1065 on radiation-induced DNA strand breaks in cultured Chinese hamster ovary cells.
Radiation research 1988;113(1):155-70.
1988: Luka Milas; Philip J Tofilon; M Iwakawa
Maturational agents alone or in combination with cytotoxic agents in therapy of tumor metastases.
Advances in experimental medicine and biology 1988;233():377-83.
1988: D Murray; S C vanAnkeren; Luka Milas; Raymond E Meyn
Radioprotective action of aminothiols in vitro and in vivo: comparison between effects on DNA damage and cell survival.
Pharmacology & therapeutics 1988;39(1-3):151-3.
1988: Luka Milas; D Murray; W A Brock; Raymond E Meyn
Radioprotectors in tumor radiotherapy: factors and settings determining therapeutic ratio.
Pharmacology & therapeutics 1988;39(1-3):179-87.
1987: M Iwakawa; Philip J Tofilon; Nancy Hunter; L C Stephens; Luka Milas
Antitumor and antimetastatic activity of the differentiating agent N-methylformamide in murine tumor systems.
Clinical & experimental metastasis 1987;5(4):289-300.
1987: Luka Milas; M Iwakawa; Nancy Hunter
Enhancement of lung colony formation by admixing irradiated with viable tumor cells: dependence on host status.
Clinical & experimental metastasis 1987;5(3):213-7.
1987: M Iwakawa; Luka Milas; Nancy Hunter; Philip J Tofilon
Modification of tumor and normal tissue radioresponse in mice by N-methylformamide.
International journal of radiation oncology, biology, physics 1987;13(1):55-60.
1987: D Murray; I Basic; Luka Milas; Raymond E Meyn
DNA cross-linking following exposure to cis-platinum in primary and serially passaged cultured cells derived from two murine fibrosarcomas.
Cancer chemotherapy and pharmacology 1987;20(2):133-6.
1986: Luka Milas; N Hunter; I Basic; J P Volpe; P J Tofilon
Effect of the radiosensitizer misonidazole and the radioprotector diethyldithiocarbamate on spontaneous metastasis formation of murine tumors.
International journal of radiation oncology, biology, physics 1986;12(7):1071-4.
1985: J P Volpe; N Hunter; I Basic; Luka Milas
Metastatic properties of murine sarcomas and carcinomas. I. Positive correlation with lung colonization and lack of correlation with s.c. tumor take.
Clinical & experimental metastasis 1985;3(4):281-94.
1985: P J Tofilon; I Basic; Luka Milas
Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.
Cancer research 1985;45(5):2025-30.